Please Enter Your Text in the Search Box!
There are no specific laws or mechanisms are in place for oversight of nanomedicine. The FDA should not attempt regulation of nanomedicine by applying existing statutes alone, espe
Evidence continues to mount that many nanoproducts inherently posses novel size-based properties and toxicity profiles. Yet, there is no specific law or mechanism for oversight of